US20050171572A1 - Multi-layer coaxial vaso-occlusive device - Google Patents

Multi-layer coaxial vaso-occlusive device Download PDF

Info

Publication number
US20050171572A1
US20050171572A1 US11089207 US8920705A US2005171572A1 US 20050171572 A1 US20050171572 A1 US 20050171572A1 US 11089207 US11089207 US 11089207 US 8920705 A US8920705 A US 8920705A US 2005171572 A1 US2005171572 A1 US 2005171572A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
vaso
element
occlusive device
device
intermediate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11089207
Inventor
George Martinez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MicroVention Inc
Original Assignee
MicroVention Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12145Coils or wires having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/1215Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • A61B17/12154Coils or wires having stretch limiting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12177Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure comprising additional materials, e.g. thrombogenic, having filaments, having fibers or being coated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12181Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
    • A61B17/1219Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004(bio)absorbable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/0084Material properties low friction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/36Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Abstract

A vaso-occlusive device includes inner, intermediate, and outer elements arranged coaxially. The inner element is a filamentous element, preferably a microcoil. The intermediate element is made of a non-metallic material, preferably an expansile polymer. The outer element is substantially non-expansile and defines at least one gap or opening through which the intermediate element is exposed. In a preferred embodiment, when the intermediate element is expanded, it protrudes through the at least one gap or opening in the outer element and assumes a configuration with an undulating, convexly-curved outer surface defining a chain of arcuate segments, each having a diameter significantly greater than the diameter of the outer element. The expanded configuration of the intermediate element minimizes friction when the device is deployed through a microcatheter, thereby reducing the likelihood of buckling while maintaining excellent flexibility. The result is a device with enhanced pushability and trackability when deployed through a microcatheter.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a Continuation-in-Part of co-pending application Ser. No. 10/631,981; filed Jul. 31, 2003, which prior application claims the benefit, under 35 U.S.C. Section 119(e), of provisional application No. 60/400,103, filed Jul. 31, 2002, the disclosure of which is incorporated herein by reference.
  • FEDERALLY-SPONSORED RESEARCH OR DEVELOPMENT
  • Not Applicable
  • BACKGROUND
  • This invention relates to vaso-occlusive devices, such as vaso-occlusive coils and the like, for the embolization of vascular aneurysms and similar vascular abnormalities. Specifically, the invention is an improvement over existing two layer or two element coaxial vaso-occlusive devices, particularly those having a polymer coating or covering. In particular, the present invention is a three layer or three element coaxial vaso-occlusive device that provides improved durability, pushability, and trackability inside a microcatheter. The characteristic termed “trackability” relates to the ease of advancing one interventional device within or over another, and it is related to friction and flexibility.
  • Vaso-occlusive devices are typically used within the vasculature of the human body to block the flow of blood through a vessel through the formation of an embolus. Vaso-occlusive devices are also used to form an embolus within an aneurysm stemming from the vessel. Vaso-occlusive devices can be formed of one or more elements, generally delivered into the vasculature via a catheter or similar mechanism.
  • The embolization of blood vessels is desired in a number of clinical situations. For example, vascular embolization has been used to control vascular bleeding, to occlude the blood supply to tumors, and to occlude vascular aneurysms, particularly intracranial aneurysms. In recent years, vascular embolization for the treatment of aneurysms has received much attention. Several different treatment modalities have been employed in the prior art. One approach that has shown promise is the use of thrombogenic microcoils. These microcoils may be made of a biocompatible metal alloy (typically platinum and tungsten) or a suitable polymer. If made of metal, the coil may be provided with Dacron fibers to increase thrombogenicity. The coil is deployed through a microcatheter to the vascular site. Examples of microcoils are disclosed in the following U.S. Pat. No. 4,994,069—Ritchart et al.; U.S. Pat. No. 5,133,731—Butler et al.; U.S. Pat. No. 5,226,911—Chee et al.; U.S. Pat. No. 5,312,415—Palermo; U.S. Pat. No. 5,382,259—Phelps et al.; U.S. Pat. No. 5,382,260—Dormandy, Jr. et al.; U.S. Pat. No. 5,476,472—Dormandy, Jr. et al.; U.S. Pat. No. 5,578,074—Mirigian; U.S. Pat. No. 5,582,619—Ken; U.S. Pat. No. 5,624,461—Mariant; U.S. Pat. No. 5,645,558—Horton; U.S. Pat. No. 5,658,308—Snyder; and U.S. Pat. No. 5,718,711—Berenstein et al.
  • A specific type of microcoil that has achieved a measure of success is the Guglielmi Detachable Coil (“GDC”), described in U.S. Pat. No. 5,122,136—Guglielmi et al. The GDC employs a platinum wire coil fixed to a stainless steel delivery wire by a solder connection. After the coil is placed inside an aneurysm, an electrical current is applied to the delivery wire, which electrolytically disintegrates the solder junction, thereby detaching the coil from the delivery wire. The application of the current also creates a positive electrical charge on the coil, which attracts negatively-charged blood cells, platelets, and fibrinogen, thereby increasing the thrombogenicity of the coil. Several coils of different diameters and lengths can be packed into an aneurysm until the aneurysm is completely filled. The coils thus create and hold a thrombus within the aneurysm, inhibiting its displacement and its fragmentation.
  • The advantages of the GDC procedure are the ability to withdraw and relocate the coil if it migrates from its desired location, and the enhanced ability to promote the formation of a stable thrombus within the aneurysm.
  • A more recent development in the field of microcoil vaso-occlusive devices is exemplified in U.S. Pat. No. 6,299,619—Greene, Jr. et al. and U.S. Pat. No. 6,602,261—Greene, Jr. et al., both assigned to the assignee of the subject invention. These patents disclose vaso-occlusive devices comprising a microcoil with one or more expansile elements disposed on the outer surface of the coil. The expansile elements may be formed of any of a number of expansile polymeric hydrogels, or alternatively, environmentally-sensitive polymers that expand in response to a change in an environmental parameter (e.g., temperature or pH) when exposed to a physiological environment, such as the blood stream.
  • While the microcoils with expansile elements have exhibit great promise in, for example, embolizing aneurysms of a wide variety of sizes and configurations, the expansile elements increase the frictional forces between the vaso-occlusive device and a microcatheter through which the device is deployed. Furthermore, depending on the configuration and material of the expansile elements, the flexibility of the device may be reduced. These factors may result in a device that has less than optimal pushability (resistance to buckling) and reduced trackability (as defined above).
  • There has thus been a long-felt, but as yet unsatisfied need for a microcoil vaso-occlusive device that has all the advantages of the expansile element type of device, and that also exhibits enhanced pushability and trackability, with good durability characteristics.
  • SUMMARY OF THE INVENTION
  • Broadly, the present invention is a vaso-occlusive device, comprising three coaxial elements: an elongate, flexible, filamentous inner element; a non-metallic intermediate element coaxially surrounding the inner element and in intimate contact therewith; and an outer element coaxially surrounding the intermediate element and in intimate contact therewith, the outer element including one or more openings or gaps through which the intermediate element is exposed.
  • In one preferred embodiment of the invention, the inner element is in the form of a helical coil made of a biocompatible, radiopaque metal, and the intermediate element is a conformal coating or layer on the inner element, the conformal coating or layer being made of a soft polymeric material that is preferably an expansile polymer. Advantageously, the polymeric hydrogel is an environmentally-responsive hydrogel that expands upon exposure to the physiological environment, for example, of the blood stream. The polymer may advantageously be bio-absorbable or biodegradable.
  • The outer element is advantageously a helical “over-coil” that is loosely wound (“open-wound”) over the intermediate element, except at proximal and distal end sections, where it is tightly wound (“close-wound”). The close-wound proximal and distal end sections support the inner element, protecting it from damage during deployment and any necessary repositioning, while also securely binding the intermediate element to the inner element at the proximal and distal ends of the device and restraining the hydrogel of the intermediate element from expanding at the respective ends of the device. The open-wound section between the proximal and distal end sections creates a single, continuous helical opening through which the intermediate element expands. The helical configuration of the opening forces the expanded polymeric intermediate element to assume the configuration of a chain of arcuate segments protruding radially outwardly between the coils of the over-coil, rather than that of a continuous polymeric layer having a continuous, uninterrupted exterior surface. Because each of the arcuate segments contacts the interior surface of a microcatheter (e.g., during deployment) primarily at or near a tangential contact point, the total contact area of the intermediate element is reduced as compared to a continuous axial polymeric element. This reduced contact area correspondingly reduces the aggregate friction between the polymeric layer and the microcatheter, thereby decreasing the resistance to manipulation of the device. The open-wound section also creates hinge points between the arcuate segments of the polymeric intermediate element, thereby increasing the overall flexibility of the device.
  • It has been confirmed experimentally that the reduced friction and increased flexibility afforded by the outer element, and by the interaction between the outer and intermediate elements, enhances the both the pushability and trackability of a device made in accordance with the present invention, as compared, for example, with prior art microcoil devices having expansile polymeric coatings or elements on or along their exterior surfaces.
  • The invention thus provides a microcoil vaso-occlusive device with an expansile element that allows the device to embolize very efficiently a wide variety of vascular abnormalities, e.g., aneurysms of a wide variety of shapes, sizes, and locations, and yet that exhibits enhanced pushability and trackability as compared to the prior art.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view of a vaso-occlusive device in accordance with a preferred embodiment of the present invention;
  • FIG. 2 is an axial cross-sectional view of the device of FIG. 1;
  • FIG. 3 is a perspective view, similar to that of FIG. 1, showing the expansile polymeric intermediate element in its expanded state;
  • FIG. 4 is an axial cross-sectional view of FIG. 3;
  • FIG. 5 is a cross-sectional view taken along line 5-5 of FIG. 2, but showing a first variant form of the invention, in which the inner element comprises two coaxial helical microcoils;
  • FIG. 6 is a cross-sectional view similar to that of FIG. 5, but showing a second variant form of the invention, in which the inner element comprises three coaxial helical microcoils;
  • FIG. 7 is a cross-sectional view similar to that of FIG. 5, but showing a third variant form of the invention, in which the inner element comprises a helical microcoil defining a lumen containing a solid coaxial core;
  • FIG. 8 is a cross-sectional view similar to that of FIG. 5, but showing a fourth variant form of the invention, in which the inner element comprises a helical microcoil defining a lumen containing a hollow, tubular coaxial core; and
  • FIG. 9 is a perspective view of an alternative embodiment of the invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Referring to FIGS. 1-4, a vaso-occlusive device 10, in accordance with a preferred embodiment of the invention, comprises three elongate, coaxial elements: an inner element 11, a non-metallic intermediate element 12, and a non-expansile outer element 13 that covers at least a portion of the intermediate element. The intermediate element 12 is in intimate contact with both the inner element 11 and the outer element 13.
  • The inner element 11 is formed of a flexible, elongate filament or wire that is preferably made of a material that allows visualization under various medical imaging means, such as X-ray, MRI, or ultrasound. Preferably, the inner element 11 is formed from a length of wire made of any of various biocompatible, radiopaque metals, such as platinum, tantalum, tungsten, gold, titanium, nitinol, stainless steel, Elgiloy (cobalt-chromium-nickel), or other suitable alloys known in the art. Alternatively, it can be made from or include non-metallic materials, such as polymers, collagen, proteins, drugs, biologic materials (e.g., cellular material and genes), bioactive agents, therapeutic compounds, or combinations of these materials. If made of a non-radiopaque material, it should advantageously be doped or impregnated or chemically modified to be visible with one or more imaging techniques. Alternatively, it can be made of a material that is highly visible by means of MRI or ultrasound. The inner element 11 can be formed in various configurations, including, but not limited to, coils, rods, tubes, cables, braids, cut tubes, or other elongate, flexible forms. As shown, it is in the form of a helical coil, which may be preferred. In one specific embodiment, it is formed at least in part of a multi-filar coil configuration, as described in the co-owned U.S. Patent Application Publication No. 2004/0006362, the disclosure of which is incorporated herein by reference.
  • The intermediate element 12 may be formed as a coating, wrapping, tubular sleeve, or other construction to create a substantially continuous surface coaxially around the inner element 11. Alternatively, it can be formed into a cylinder and then skewered onto the inner core element 11, as described in the co-owned and co-pending U.S. Patent Application Publication No. 2002/0177855, the disclosure of which is incorporated herein by reference. The intermediate element 12 preferably covers all of the length of the inner element 11, except for short proximal and distal sections.
  • The intermediate element 12 may be made of any of various suitable, substantially non-metallic, biocompatible materials, including polymers, biopolymers, biologic materials, and combinations of these materials. Suitable polymers include cellulose, polypropylene, polyvinylpyrrolidone, polyacrylics, polylactides, polyamides, polyvinyl alcohol (PVA), polyester, polyurethane, polyglycolic acid, polyfluorocarbons (e.g., PTFE), nylon, polymethylmethacrylate (PMMA), hydrogels, and silicones. Exemplary biologic materials include alginates, hyaluronic acid, fibrin, collagen and silk. Optionally, the intermediate element 12 can be impregnated, grafted, bound, or modified to deliver therapeutic compounds, drugs, collagen, proteins, genes, bioactive agents, or cellular material. See, e.g., U.S. Pat. No. 5,658,308 and International Publications Nos. WO 99/65401 and WO 00/27445, the disclosures of which are incorporated herein by reference. In one preferred embodiment, the intermediate element 12 is made of a state-of-the-art bioabsorbable or biodegradable polymer, such as, for example, those described in U.S. Patent Application Publications Nos. 2002/0040239 and 2002/0020417, the disclosures of which are incorporated herein by reference. In another preferred embodiment, the intermediate element 12 is made of a soft conformal material, and more preferably of an expansile material such as a hydrogel.
  • The most preferred material is an environmentally responsive hydrogel, such as that described in U.S. Patent Application Publication No. 2002/0176880, the disclosure of which is incorporated herein by reference. Specifically, the hydrogels described in U.S. Patent Application Publication No. 2002/0176880 are of a type that undergoes controlled volumetric expansion in response to changes in such environmental parameters as pH or temperature. These hydrogels are prepared by forming a liquid mixture that contains (a) at least one monomer and/or polymer, at least a portion of which is sensitive to changes in an environmental parameter; (b) a cross-linking agent; and (c) a polymerization initiator. If desired, a porosigen (e.g., NaCl, ice crystals, or sucrose) may be added to the mixture, and then removed from the resultant solid hydrogel to provide a hydrogel with sufficient porosity to permit cellular ingrowth. The controlled rate of expansion is provided through the incorporation of ethylenically unsaturated monomers with ionizable functional groups (e.g., amines, carboxylic acids). For example, if acrylic acid is incorporated into the crosslinked network, the hydrogel is incubated in a low pH solution to protonate the carboxylic acids. After the excess low pH solution is rinsed away and the hydrogel dried, the hydrogel can be introduced through a microcatheter filled with saline at physiological pH or with blood. The hydrogel cannot expand until the carboxylic acid groups deprotonate. Conversely, if an amine-containing monomer is incorporated into the crosslinked network, the hydrogel is incubated in a high pH solution to deprotonate amines. After the excess high pH solution is rinsed away and the hydrogel dried, the hydrogel can be introduced through a microcatheter filled with saline at physiological pH or with blood. The hydrogel cannot expand until the amine groups protonate.
  • More specifically, in a preferred formulation of the hydrogel, the monomer solution is comprised of ethylenically unsaturated monomers, an ethylenically unsaturated crosslinking agent, a porosigen, and a solvent. At least a portion, preferably 10%-50%, and more preferably 10%-30%, of the monomers selected must be pH sensitive. The preferred pH sensitive monomer is acrylic acid. Methacrylic acid and derivatives of both acids will also impart pH sensitivity. Since the mechanical properties of hydrogels prepared exclusively with these acids are poor, a monomer to provide additional mechanical properties should be selected. A preferred monomer for providing mechanical properties is acrylamide, which may be used in combination with one or more of the above-mentioned pH sensitive monomers to impart additional compressive strength or other mechanical properties. Preferred concentrations of the monomers in the solvent range from 20% w/w to 30% w/w.
  • The crosslinking agent can be any multifunctional ethylenically unsaturated compound, preferably N,N′-methylenebisacrylamide. If biodegradation of the hydrogel material is desired, a biodegradable crosslinking agent should be selected. The concentrations of the crosslinking agent in the solvent should be less than about 1% w/w, and preferably less than about 0.1% w/w.
  • The porosity of the hydrogel material is provided by a supersaturated suspension of a porosigen in the monomer solution. A porosigen that is not soluble in the monomer solution, but is soluble in the washing solution can also be used. Sodium chloride is the preferred porosigen, but potassium chloride, ice, sucrose, and sodium bicarbonate can also be used. It is preferred to control the particle size of the porosigen to less than about 25 microns, more preferably less than about 10 microns. The small particle size aids in the suspension of the porosigen in the solvent. Preferred concentrations of the porosigen range from about 5% w/w to about 50% w/w, more preferably about 10% w/w to about 20% w/w, in the monomer solution. Alternatively, the porosigen can be omitted and a non-porous hydrogel can be fabricated.
  • The solvent, if necessary, is selected based on the solubilities of the monomers, crosslinking agent, and porosigen. If a liquid monomer (e.g. 2-hydroxyethyl methacrylate) is used, a solvent is not necessary. A preferred solvent is water, but ethyl alcohol can also be used. Preferred concentrations of the solvent range from about 20% w/w to about 80% w/w, more preferably about 50% w/w to about 80% w/w.
  • The crosslink density substantially affects the mechanical properties of these hydrogel materials. The crosslink density (and hence the mechanical properties) can best be manipulated through changes in the monomer concentration, crosslinking agent concentration, and solvent concentration. The crosslinking of the monomer can be achieved through reduction-oxidation, radiation, and heat. Radiation crosslinking of the monomer solution can be achieved with ultraviolet light and visible light with suitable initiators or ionizing radiation (e.g. electron beam or gamma ray) without initiators. A preferred type of crosslinking initiator is one that acts via reduction-oxidation. Specific examples of such red/ox initiators that may be used in this embodiment of the invention are ammonium persulfate and N,N,N′,N′-tetramethylethylenediamine.
  • After the polymerization is complete, the hydrogen is washed with water, alcohol or other suitable washing solution(s) to remove the porosigen(s), any unreacted, residual monomer(s) and any unincorporated oligomers. Preferably this is accomplished by initially washing the hydrogel in distilled water.
  • As discussed above, the control of the expansion rate of the hydrogel is achieved through the protonation/deprotonation of ionizable functional groups present on the hydrogel network. Once the hydrogel has been prepared and the excess monomer and porosigen have been washed away, the steps to control the rate of expansion can be performed.
  • In embodiments where pH sensitive monomers with carboxylic acid groups have been incorporated into the hydrogel network, the hydrogel is incubated in a low pH solution. The free protons in the solution protonate the carboxylic acid groups on the hydrogel network. The duration and temperature of the incubation and the pH of the solution influence the amount of control on the expansion rate. Generally, the duration and temperature of the incubation are directly proportional to the amount of expansion control, while the solution pH is inversely proportional. It has been determined that the water content of the treating solution also affects the expansion control. In this regard, the hydrogel is able to expand more in the treating solution and it is presumed that an increased number of carboxylic acid groups are available for protonation. An optimization of water content and pH is required for maximum control on the expansion rate. After the incubation is concluded, the excess treating solution is washed away and the hydrogel material is dried. The hydrogel treated with the low pH solution has been observed to dry down to a smaller dimension than the untreated hydrogel. This is a desired effect since delivery of these hydrogel materials through a microcatheter is desired.
  • If pH sensitive monomers with amine groups were incorporated into the hydrogel network, the hydrogel is incubated in high pH solution. Deprotonation occurs on the amine groups of the hydrogel network at high pH. The duration and temperature of the incubation, and the pH of the solution, influence the amount of control on the expansion rate. Generally, the duration, temperature, and solution pH of the incubation are directly proportional to the amount of expansion control. After the incubation is concluded, the excess treating solution is washed away and the hydrogel material is dried.
  • For the embodiment of the vaso-occlusive device having an intermediate element formed of an expansile polymeric hydrogel, when the intermediate element 12 expands, the areas of the soft, conformal intermediate element 12 that are not covered or constrained by the outer element 13 extend radially outward through the openings or gaps, or between the coils of the outer element 13 (as described below) to form an undulating outer surface comprising a chain of arcuate segments, as a result of the constraint imposed by the outer element 13. Because the arcuate segments of the undulating outer surface contact the interior wall surface of a microcatheter through which the device is deployed only at or near tangential contact points proximate the apex of each segment, this undulating or arcuate configuration provides reduced friction as compared to a continuous or smooth surface of the same material.
  • The outer element 13 is a flexible, elongate, substantially tubular member, at least a substantial portion of the length of which, and preferably most of the length of which, includes or defines at least one opening or gap to allow the exposure and/or protrusion of the intermediate element 12. Suitable configurations for the outer element 13 include helical coils, braids, and slotted or spiral-cut tubes. The outer element 13 may be made of any suitable biocompatible metal or polymer, including those listed above for the inner element 11. For those embodiments using a soft, conformal intermediate element 12, the outer element 13 should have sufficient radial strength to compress or restrain the intermediate element 12.
  • Preferably, the openings in the outer element 13 are such that, along a substantial portion of the length of the device, the open area of the outer element 13 is at least about 20%, and more preferably, more than about 40%, of the total external surface area of the device between the proximal and distal limits of that portion of the device length. For example, near the ends of the device, the outer element 13 may have a relatively low percentage of open area (i.e., less than about 20%), while for the greater part of the length of the device between the end portions thereof, a greater percentage (i.e., at least about 20%, and preferably more than about 40%) of the outer element 13 may be open, allowing a greater exposure of the intermediate element 12 through the outer element 13. Preferably, the portion of the outer element 13 covering at least about 75% of the overall length of the device will have the greater percentage of open area.
  • In the most preferred embodiment, the device comprises an inner element 11 formed of a tightly-wound (“close-wound”) helical coil of a biocompatible metal wire (e.g., platinum alloy), an intermediate element 12 of a hydrophilic expansile polymer (e.g., hydrogel), and an outer element 13 in the form of a biocompatible metal or polymer helical coil that is open-wound for most of its length, with a close-wound proximal end section 14 and a close-wound distal end section 15. The open-wound portion of the outer element 13 defines a single, continuous, helical opening or gap. The coil is preferably made from a wire that has a diameter of no more than about 0.15 mm. The pitch of the coil of which the outer element 13 is comprised may be up to ten times the diameter of filament from which the coil is wound, and preferably between about 5 percent and about 100 percent greater than the diameter of the filament.
  • A coupling element 16 is advantageously attached to the proximal end of the inner element 11 for detachable attachment to a deployment device (not shown). A rounded obturator tip 17 may be attached to the distal end of the inner element 11.
  • In the above-described most preferred embodiment, the hydrogel of the intermediate element 12 expands or swells upon exposure to an aqueous environment (e.g., blood). Preferably, the hydrogel expands to between about two times and about 20 times its original volume. As shown in FIGS. 3 and 4, the swollen or expanded intermediate element 12 protrudes through the helical opening or gap defined between the coils of the open-wound section of the outer element 13 to form an undulating, convexly-curved surface defining a chain of arcuate or rounded segments, each having a diameter that is substantially greater than the diameter of the outer element 13.
  • The helical outer element 13 described above may be considered as defining a single, helical opening or gap, or it may be viewed as defining a plurality of connected openings or gaps, each defined between an adjacent pair of windings of the coil of the outer element 13. Alternatively, if the outer element 13 is formed as a slotted tube, for example, the outer element 13 will be seen to define a plurality of discrete openings or gaps in its axial middle section that are functionally equivalent to the helical opening(s) defined in the illustrated embodiment.
  • The device 10 can be constructed with various radial thickness of each coaxial element to provide different handling characteristics. Preferably, the inner element 11 has a diameter of between about 0.075 mm and 0.75 mm; the intermediate element 12 has a thickness of between about 0.025 mm and 1.00 mm; and the outer element 13 has a thickness of between about 0.025 mm and 0.25 mm. For the embodiments that use an expansile intermediate element 12, these thicknesses are measured in the non-expanded state. Preferably, the outer diameter of the outer element 13 is actually somewhat less than the expanded or swollen diameter of the intermediate element 12, so that the latter will readily expand through the openings or gaps in the outer element 13.
  • FIGS. 5 and 6 illustrate variants of the preferred embodiment of the invention, with multilayer structures for the inner element. Specifically, FIG. 5 shows a first variant having an inner element comprising first and second coaxial coils 110 a, 110 b, respectively. FIG. 6 shows a second variant having an inner element comprising first, second, and third coaxial coils 210 a, 210 b, and 210 c, respectively. Suitable coaxial coil structures and their methods of manufacture are disclosed in commonly owned and co-pending U.S. Patent Application Publication No. 2004/0006363, the disclosure of which is incorporated herein by reference. The inner element may, in fact, comprise four or more coaxial layers. Similarly, the outer element 13 may comprise multiple coaxial helical coil layers, provided that a suitable percentage of the surface area of the outer element remains open for the exposure of the intermediate element, as explained above.
  • FIG. 7 illustrates a third variant of the present invention, in which the inner element comprises a helical coil 310 defining an axial lumen, at least a substantial portion of the length of which is filled with a solid core member 320. The solid core member 320 may be impregnated with a therapeutic agent that can be absorbed into the bloodstream.
  • FIG. 8 illustrates a fourth variant of the invention, in which the inner element comprises a helical coil 410 defining an axial lumen, at least a substantial portion of which contains a hollow, tubular core member 420. The tubular core member 340 provides additional strength, and it may be filled with a liquid therapeutic agent (not shown).
  • FIG. 9 shows a vaso-occlusive device 10′ in accordance with an alternative embodiment of the invention. This embodiment includes an outer element 13′ with a distal section 15′ that is not close wound, but is, instead, made with small gaps of approximately 5% to 100% of the diameter of the wire or filament of which the outer element 13′ is made. These gaps make the distal section 15′ of the device 10′ more flexible in the area where the outer element 13′ overlaps the inner element 11′.
  • In the embodiment shown in FIG. 9, the proximal ends of both the inner element 11′ and the outer element 13′ are both advantageously attached to a coupling element 16′ by soldering or welding. The attachment of both the inner element 11′ and the outer element 13′ to the coupling element 16′ makes the proximal end of the device 10′ more resistant to deformation during deployment and implantation.
  • In any of the embodiments described above, a portion of the outer element and/or a portion of the intermediate element may be modified (as by coating, for example) to include structure that promotes the adhesion of beneficial cells or growth factors. An exemplary coating that be used for this purpose is disclosed in U.S. Patent Application Publication No. 2002/0049495, the disclosure of which is incorporated herein by reference.
  • As indicated above, the present invention provides good trackability in a microcatheter. In other words, it is easily advanced through a catheter without binding against or moving the catheter. This advantage is achieved through reduced friction and reduced buckling at the ends of the device. The force required to advance the device through a typical microcatheter would normally be less than about 0.7 lbs.
  • The device is preferably detachable from a flexible, elongate delivery apparatus (not shown), such as a wire, a pusher tube, or the like. Exemplary detachment systems known in the art include electrolytic, mechanical, electromechanical, thermal, ultrasonic, and hydraulic detachment mechanisms. The device may be formed into a secondary configuration, such as a helical coil, a sphere, an ovoid, or any other suitable two- or three-dimensional shape known in the art of vaso-occlusive devices. Alternatively, the device can be left in a relatively straight configuration with or without a curvature at the end (such as a “J” configuration).
  • In any of the above-described embodiments, either the inner element or the intermediate element, or both, may be formed so as to be substantially stretch-resistant, so as to limit the stretching of the entire device (including the outer element) if the device needs to be partially withdrawn for repositioning or the like. It will be appreciated that a number of the materials discussed above will be stretch-resistant to varying degrees.
  • The device is useful for the occlusion and/or embolization of blood vessels, other vascular spaces such as aneurysms, and other tubular or saccular organs or spaces throughout the body. Specific applications where it may be useful include the occlusion of cerebral aneurysms, aortic aneurysms, fistulas, fallopian tubes, cardiac septal defects, patent foramen ovale, and the left atrial appendage of the heart. For some of these applications, it may be preferable to use devices with dimensions larger than those specified above.
  • Although preferred embodiments of the invention have been described in this specification and the accompanying drawings, it will be appreciated that a number of variations and modifications may suggest themselves to those skilled in the pertinent arts. Thus, the scope of the present invention is not limited to the specific embodiments and examples described herein, but should be deemed to encompass alternative embodiments and equivalents, as determined by a fair reading of the claims that follow.

Claims (25)

  1. 1. A vaso-occlusive device, comprising:
    an elongate, flexible, filamentous inner element;
    a non-metallic intermediate element coaxially surrounding the inner element and in intimate contact therewith; and
    an outer element coaxially surrounding the intermediate element, the outer element defining an open area through which the intermediate element is exposed;
    wherein along a substantial predetermined portion of the length of the device, the open area constitutes at least about 20 percent of the surface area of device within the predetermined portion of its length.
  2. 2. The vaso-occlusive device of claim 1, wherein the intermediate element includes an expansile polymeric material
  3. 3. The vaso-occlusive device of claim 1, wherein the outer element includes a helical coil having a pitch that defines the open area through which the intermediate element is exposed.
  4. 4. The vaso-occlusive device of claim 3, wherein the coil is formed of a helically-wound filament, and wherein the pitch of the coil is greater than the diameter of the filament.
  5. 5. The vaso-occlusive device of claim 4, wherein the pitch of the coil is between about 5 percent and about 100 percent greater than the diameter of the filament.
  6. 6. The vaso-occlusive device of claim 2, wherein the expansile polymeric material comprises a hydrogel.
  7. 7. The vaso-occlusive device of claim 6, wherein the expansile polymeric material consists essentially of a hydrogel.
  8. 8. The vaso-occlusive device of claim 7, wherein the hydrogel is of a type that expands in response to a change in an environmental parameter.
  9. 9. The vaso-occlusive device of claim 8, wherein the environmental parameter is selected from the group consisting of temperature and pH.
  10. 10. The vaso-occlusive device of claim 1, wherein the inner element comprises at least two concentric microcoils.
  11. 11. The vaso-occlusive device of claim 1, wherein the inner element defines a lumen containing a hollow, tubular core element.
  12. 12. The vaso-occlusive device of claim 1, wherein the inner element defines a lumen containing a substantially solid core element.
  13. 13. The vaso-occlusive device of claim 1, wherein at least one of the inner element and the intermediate element includes a material selected from the group consisting of at least one of a drug, a bioactive agent, a therapeutic compound, cellular material, genes, collagen, and protein.
  14. 14. A vaso-occlusive device comprising:
    a filamentous inner element;
    a non-metallic intermediate element coaxially surrounding the inner element and in intimate contact therewith; and
    an outer element coaxially surrounding the intermediate element and having an open area through which the intermediate element is exposed, the outer element comprising a helically-wound filament defining a helical coil having a pitch that is greater than the diameter of the filament.
  15. 15. The vaso-occlusive device of claim 14, wherein at least one of the inner and intermediate elements is made at least in part of a non-metallic biocompatible material.
  16. 16. The vaso-occlusive device of claim 15, wherein the pitch of the coil is between about 5 percent and about 100 percent greater than the diameter of the filament.
  17. 17. The vaso-occlusive device of claim 14, wherein the inner element comprises a microcoil made of a biocompatible material selected from the group consisting of metal wire and polymeric filament, and wherein the intermediate element is formed of a biocompatible polymeric material
  18. 18. The vaso-occlusive device of claim 14, wherein the intermediate element includes an expansile polymeric material
  19. 19. The vaso-occlusive device of claim 14, wherein along a substantial predetermined portion of the length of the device, the open area constitutes at least about 20 percent of the surface area of device within the predetermined portion of its length.
  20. 20. The vaso-occlusive device of claim 18, wherein the expansile polymeric material comprises a hydrogel.
  21. 21. The vaso-occlusive device of claim 20, wherein the expansile polymeric material consists essentially of a hydrogel.
  22. 22. The vaso-occlusive device of claim 21, wherein the hydrogel is of a type that expands in response to a change in an environmental parameter.
  23. 23. The vaso-occlusive device of claim 22, wherein the environmental parameter is selected from the group consisting of temperature and pH.
  24. 24. The vaso-occlusive device of claim 14, wherein the inner element has proximal and distal ends, and wherein the outer element comprises an open-wound helical coil portion extending between proximal and distal end sections that are respectively attached to the inner element adjacent to the proximal and distal ends of the inner element, wherein the open-wound portion defines the open area.
  25. 25. The vaso-occlusive device of claim 14, wherein at least one of the inner element and the intermediate element includes a material selected from the group consisting of at least one of a drug, a bioactive agent, a therapeutic compound, cellular material, genes, collagen, and protein.
US11089207 2002-07-31 2005-03-24 Multi-layer coaxial vaso-occlusive device Abandoned US20050171572A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US40001302 true 2002-07-31 2002-07-31
US10631981 US8273100B2 (en) 2002-07-31 2003-07-31 Three element coaxial vaso-occlusive device
US11089207 US20050171572A1 (en) 2002-07-31 2005-03-24 Multi-layer coaxial vaso-occlusive device

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US11089207 US20050171572A1 (en) 2002-07-31 2005-03-24 Multi-layer coaxial vaso-occlusive device
EP20060739146 EP1868511A1 (en) 2005-03-24 2006-03-17 Multi-layer coaxial vaso-occlusive device
PCT/US2006/010241 WO2006102329A1 (en) 2005-03-24 2006-03-17 Multi-layer coaxial vaso-occlusive device
JP2008503095A JP2008534057A (en) 2005-03-24 2006-03-17 Multi-layer coaxial vascular occlusion device
CN 200680018280 CN101198280B (en) 2005-03-24 2006-03-17 Multi-layer coaxial vaso-occlusive device
CA 2601712 CA2601712A1 (en) 2005-03-24 2006-03-17 Multi-layer coaxial vaso-occlusive device
CN 201010277996 CN101978934B (en) 2003-07-31 2006-03-17 Multi-layer coaxial vaso-occlusive device
US13164446 US8764788B2 (en) 2002-07-31 2011-06-20 Multi-layer coaxial vaso-occlusive device

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10631981 Continuation-In-Part US8273100B2 (en) 2002-07-31 2003-07-31 Three element coaxial vaso-occlusive device
US10631981 Continuation US8273100B2 (en) 2002-07-31 2003-07-31 Three element coaxial vaso-occlusive device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13164446 Continuation US8764788B2 (en) 2002-07-31 2011-06-20 Multi-layer coaxial vaso-occlusive device

Publications (1)

Publication Number Publication Date
US20050171572A1 true true US20050171572A1 (en) 2005-08-04

Family

ID=36577531

Family Applications (2)

Application Number Title Priority Date Filing Date
US11089207 Abandoned US20050171572A1 (en) 2002-07-31 2005-03-24 Multi-layer coaxial vaso-occlusive device
US13164446 Active 2023-09-04 US8764788B2 (en) 2002-07-31 2011-06-20 Multi-layer coaxial vaso-occlusive device

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13164446 Active 2023-09-04 US8764788B2 (en) 2002-07-31 2011-06-20 Multi-layer coaxial vaso-occlusive device

Country Status (6)

Country Link
US (2) US20050171572A1 (en)
EP (1) EP1868511A1 (en)
JP (1) JP2008534057A (en)
CN (1) CN101198280B (en)
CA (1) CA2601712A1 (en)
WO (1) WO2006102329A1 (en)

Cited By (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040098028A1 (en) * 2002-07-31 2004-05-20 George Martinez Three element coaxial vaso-occlusive device
US20060079926A1 (en) * 2004-10-07 2006-04-13 Rupesh Desai Vasoocclusive coil with biplex windings to improve mechanical properties
US20060173488A1 (en) * 2003-02-20 2006-08-03 Masahiro Takeuchi Indwelling instrument for forming embolus
US20060241690A1 (en) * 2004-03-19 2006-10-26 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US20070213825A1 (en) * 2006-02-13 2007-09-13 Lanx, Llc Method and apparatus for intervertebral disc support and repair
US20070265656A1 (en) * 2004-03-19 2007-11-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US20080027561A1 (en) * 2006-07-31 2008-01-31 Vladimir Mitelberg Interventional medical device system having an elongation retarding portion and method of using the same
US20080046093A1 (en) * 2006-08-18 2008-02-21 Richard Champion Davis Stretch resistant embolic coil
US20080097398A1 (en) * 2006-07-31 2008-04-24 Vladimir Mitelberg Interventional medical device component having an interrupted spiral section and method of making the same
US20080200945A1 (en) * 2004-03-19 2008-08-21 Aga Medical Corporation Device for occluding vascular defects
US20080306440A1 (en) * 2007-03-27 2008-12-11 Eran Hirszowicz Spiral balloon catheter
US20090062841A1 (en) * 2004-03-19 2009-03-05 Aga Medical Corporation Device for occluding vascular defects
US20090210048A1 (en) * 2008-02-18 2009-08-20 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US20090318892A1 (en) * 2008-06-20 2009-12-24 Maria Aboytes Removable Core Implant Delivery Catheter
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
US7803395B2 (en) 2003-05-15 2010-09-28 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US20100268201A1 (en) * 2009-04-15 2010-10-21 Microvention, Inc. Implant Delivery System
US20100268204A1 (en) * 2009-04-15 2010-10-21 Microvention, Inc. Implant Delivery System
US20110094519A1 (en) * 2009-10-23 2011-04-28 Vidya Gopal Contraceptive devices and methods
US20110184455A1 (en) * 2009-10-26 2011-07-28 Microvention, Inc. Embolization Device Constructed From Expansile Polymer
US20110184454A1 (en) * 2010-01-27 2011-07-28 Penumbra, Inc. Embolic implants
US8062325B2 (en) 2006-07-31 2011-11-22 Codman & Shurtleff, Inc. Implantable medical device detachment system and methods of using the same
US20120089174A1 (en) * 2010-10-12 2012-04-12 Boston Scientific Scimed, Inc Vaso-occlusive device
US8192480B2 (en) 2007-12-21 2012-06-05 Microvention, Inc. System and method of detecting implant detachment
US20120303053A1 (en) * 2011-05-23 2012-11-29 Stryker Nv Operations Limited Vaso-occlusive devices with in-situ stiffening
US8360765B2 (en) 2011-01-07 2013-01-29 Covidien Lp Systems and method for forming a coaxial implant
US20130131711A1 (en) * 2011-11-23 2013-05-23 Microvention, Inc. Embolic Device With Shaped Wire
WO2013109784A1 (en) * 2012-01-17 2013-07-25 Endoshape, Inc. Occlusion device for a vascular or biological lumen
US20140000631A1 (en) * 2012-06-29 2014-01-02 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US8764788B2 (en) 2002-07-31 2014-07-01 Microvention, Inc. Multi-layer coaxial vaso-occlusive device
US8801747B2 (en) 2007-03-13 2014-08-12 Covidien Lp Implant, a mandrel, and a method of forming an implant
US20140277004A1 (en) * 2013-03-13 2014-09-18 Mallik Thatipelli Device and Method for Treating a Chronic Total Occlusion
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9050095B2 (en) 2004-09-22 2015-06-09 Covidien Lp Medical implant
US9114200B2 (en) 2009-09-24 2015-08-25 Microvention, Inc. Injectable hydrogel filaments for biomedical uses
US20150250981A1 (en) * 2012-10-22 2015-09-10 Medtronic Ardian Luxembourg S.A.R.L. Catheters with enhanced flexibility and associated devices, systems, and methods
US9242070B2 (en) 2007-12-21 2016-01-26 MicronVention, Inc. System and method for locating detachment zone of a detachable implant
US9259228B2 (en) 2006-06-15 2016-02-16 Microvention, Inc. Embolization device constructed from expansile polymer
US9307996B2 (en) 2005-12-13 2016-04-12 DePuy Synthes Products, Inc. Detachment actuator for use with medical device deployment systems
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9381109B2 (en) 2010-03-19 2016-07-05 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9381278B2 (en) 2012-04-18 2016-07-05 Microvention, Inc. Embolic devices
US20160206419A1 (en) * 2015-01-20 2016-07-21 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US9399115B2 (en) 2012-10-22 2016-07-26 Medtronic Ardian Luxembourg S.A.R.L. Catheters with enhanced flexibility and associated devices, systems, and methods
WO2016154634A1 (en) * 2015-03-26 2016-09-29 Boston Scientific Scimed, Inc. Biologic-based expandable occlusion devices
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
US9486221B2 (en) 2007-12-21 2016-11-08 Microvision, Inc. Hydrogel filaments for biomedical uses
US9510922B2 (en) 2010-05-21 2016-12-06 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9561125B2 (en) 2010-04-14 2017-02-07 Microvention, Inc. Implant delivery device
US9681876B2 (en) 2013-07-31 2017-06-20 EMBA Medical Limited Methods and devices for endovascular embolization
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9707122B2 (en) 2010-07-26 2017-07-18 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US9808252B2 (en) 2009-04-02 2017-11-07 Endoshape, Inc. Vascular occlusion devices
US10010328B2 (en) 2015-10-09 2018-07-03 NeuVT Limited Endovascular occlusion device with hemodynamically enhanced sealing and anchoring

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5580737B2 (en) * 2007-08-17 2014-08-27 ミクラス エンドバスキュラー エルエルシー For vascular treatment twist primary wind coil and its formation method, the secondary wind coil
WO2009053952A3 (en) * 2007-10-26 2009-12-10 Mednua Limited A medical device for use in treatment of a valve
WO2011110177A1 (en) * 2010-03-09 2011-09-15 Lina Medical Aps Contraceptive device
WO2015100297A1 (en) * 2013-12-26 2015-07-02 Stryker Corporation Vaso-occlusive coil with bending sections

Citations (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6171326B2 (en) *
US23325A (en) * 1859-03-22 Filter
US46518A (en) * 1865-02-21 Henry wurtz
US3749085A (en) * 1970-06-26 1973-07-31 J Willson Vascular tissue removing device
US4020829A (en) * 1975-10-23 1977-05-03 Willson James K V Spring guide wire with torque control for catheterization of blood vessels and method of using same
US4493329A (en) * 1982-08-19 1985-01-15 Lynn Crawford Implantable electrode having different stiffening and curvature maintaining characteristics along its length
US4509504A (en) * 1978-01-18 1985-04-09 Medline Ab Occlusion of body channels
US4932419A (en) * 1988-03-21 1990-06-12 Boston Scientific Corporation Multi-filar, cross-wound coil for medical devices
US4951677A (en) * 1988-03-21 1990-08-28 Prutech Research And Development Partnership Ii Acoustic imaging catheter and the like
US5154705A (en) * 1987-09-30 1992-10-13 Lake Region Manufacturing Co., Inc. Hollow lumen cable apparatus
US5165421A (en) * 1987-09-30 1992-11-24 Lake Region Manufacturing Co., Inc. Hollow lumen cable apparatus
US5217484A (en) * 1991-06-07 1993-06-08 Marks Michael P Retractable-wire catheter device and method
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5415634A (en) * 1990-08-23 1995-05-16 Devices For Vascular Intervention, Inc. Catheter having helical inflation lumen
US5483022A (en) * 1994-04-12 1996-01-09 Ventritex, Inc. Implantable conductor coil formed from cabled composite wire
US5536274A (en) * 1991-02-15 1996-07-16 pfm Produkterfur Die Medizin Spiral implant for organ pathways
US5582619A (en) * 1995-06-30 1996-12-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5690666A (en) * 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5690671A (en) * 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US5690667A (en) * 1996-09-26 1997-11-25 Target Therapeutics Vasoocclusion coil having a polymer tip
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5766192A (en) * 1995-10-20 1998-06-16 Zacca; Nadim M. Atherectomy, angioplasty and stent method and apparatus
US5823198A (en) * 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5833705A (en) * 1995-06-30 1998-11-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
US5833658A (en) * 1996-04-29 1998-11-10 Levy; Robert J. Catheters for the delivery of solutions and suspensions
US5853418A (en) * 1995-06-30 1998-12-29 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US5976162A (en) * 1996-04-10 1999-11-02 Target Therapeutics, Inc. Soft-ended fibered micro vaso-occlusive devices
US6013084A (en) * 1995-06-30 2000-01-11 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US6015424A (en) * 1998-04-28 2000-01-18 Microvention, Inc. Apparatus and method for vascular embolization
US6063111A (en) * 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6136015A (en) * 1998-08-25 2000-10-24 Micrus Corporation Vasoocclusive coil
US6159165A (en) * 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US6168570B1 (en) * 1997-12-05 2001-01-02 Micrus Corporation Micro-strand cable with enhanced radiopacity
US6171326B1 (en) * 1998-08-27 2001-01-09 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US6179857B1 (en) * 1999-02-22 2001-01-30 Cordis Corporation Stretch resistant embolic coil with variable stiffness
US6231590B1 (en) * 1998-11-10 2001-05-15 Scimed Life Systems, Inc. Bioactive coating for vaso-occlusive devices
US6238403B1 (en) * 1999-10-04 2001-05-29 Microvention, Inc. Filamentous embolic device with expansible elements
US6245090B1 (en) * 1997-11-07 2001-06-12 Salviac Limited Transcatheter occluding implant
US6280457B1 (en) * 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
US6287318B1 (en) * 1998-02-13 2001-09-11 Target Therapeutics, Inc. Vaso-occlusive device with attached polymeric materials
US6296661B1 (en) * 2000-02-01 2001-10-02 Luis A. Davila Self-expanding stent-graft
US6299604B1 (en) * 1998-08-20 2001-10-09 Cook Incorporated Coated implantable medical device
US6299627B1 (en) * 1998-06-18 2001-10-09 Target Therapeutics, Inc. Water-soluble coating for bioactive vasoocclusive devices
US6312421B1 (en) * 1999-07-23 2001-11-06 Neurovasx, Inc. Aneurysm embolization material and device
US6379382B1 (en) * 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US6399886B1 (en) * 1997-05-02 2002-06-04 General Science & Technology Corp. Multifilament drawn radiopaque high elastic cables and methods of making the same
US20020169473A1 (en) * 1999-06-02 2002-11-14 Concentric Medical, Inc. Devices and methods for treating vascular malformations
US20030208221A1 (en) * 2002-05-02 2003-11-06 Fozan El-Nounou Catheter with a coiled support member
US6645237B2 (en) * 1999-02-26 2003-11-11 Vascular Architects, Inc. Expandable coiled endoluminal prosthesis
US6699277B1 (en) * 2000-03-09 2004-03-02 Diseno Y Desarrollo Medica, S.A. De C.V. Stent with cover connectors
US6723108B1 (en) * 2000-09-18 2004-04-20 Cordis Neurovascular, Inc Foam matrix embolization device

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304232A (en) 1979-03-14 1981-12-08 Alza Corporation Unit system having multiplicity of means for dispensing useful agent
US4994069A (en) 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5133731A (en) 1990-11-09 1992-07-28 Catheter Research, Inc. Embolus supply system and method
US6524274B1 (en) 1990-12-28 2003-02-25 Scimed Life Systems, Inc. Triggered release hydrogel drug delivery system
US5843089A (en) * 1990-12-28 1998-12-01 Boston Scientific Corporation Stent lining
US5304121A (en) * 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
CA2117088A1 (en) 1991-09-05 1993-03-18 David R. Holmes Flexible tubular device for use in medical applications
US5226911A (en) 1991-10-02 1993-07-13 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5258042A (en) * 1991-12-16 1993-11-02 Henry Ford Health System Intravascular hydrogel implant
US5295959A (en) * 1992-03-13 1994-03-22 Medtronic, Inc. Autoperfusion dilatation catheter having a bonded channel
US5312415A (en) 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
US5382260A (en) 1992-10-30 1995-01-17 Interventional Therapeutics Corp. Embolization device and apparatus including an introducer cartridge and method for delivering the same
CA2150707A1 (en) 1992-12-01 1994-06-09 Mir A. Imram Vibratory element for crossing stenoses
US5578074A (en) 1994-12-22 1996-11-26 Target Therapeutics, Inc. Implant delivery method and assembly
US5814062A (en) 1994-12-22 1998-09-29 Target Therapeutics, Inc. Implant delivery assembly with expandable coupling/decoupling mechanism
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
WO1998001421A1 (en) 1996-07-10 1998-01-15 University Of Utah Research Foundation pH SENSITIVE HYDROGELS WITH ADJUSTABLE SWELLING KINETICS FOR COLON-SPECIFIC DELIVERY OF PEPTIDES AND PROTEINS
US6096034A (en) 1996-07-26 2000-08-01 Target Therapeutics, Inc. Aneurysm closure device assembly
WO1999044538A1 (en) 1998-01-27 1999-09-10 The Regents Of The University Of California Biodegradable polymer/protein based coils for intralumenal implants
US6605294B2 (en) 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6602261B2 (en) 1999-10-04 2003-08-05 Microvention, Inc. Filamentous embolic device with expansile elements
US6623450B1 (en) 1999-12-17 2003-09-23 Advanced Cardiovascular Systems, Inc. System for blocking the passage of emboli through a body vessel
WO2002005731A1 (en) 2000-07-18 2002-01-24 Teitelbaum George P Biocompatible, expansile material and stent
EP1406536A4 (en) * 2001-06-20 2005-09-21 Microvention Inc Medical devices having full or partial polymer coatings and their methods of manufacture
US7572288B2 (en) * 2001-07-20 2009-08-11 Microvention, Inc. Aneurysm treatment device and method of use
US20040006354A1 (en) * 2002-07-02 2004-01-08 Dean Schaefer Coaxial stretch-resistant vaso-occlusive device
US20050171572A1 (en) 2002-07-31 2005-08-04 Microvention, Inc. Multi-layer coaxial vaso-occlusive device
US8273100B2 (en) * 2002-07-31 2012-09-25 Microvention, Inc. Three element coaxial vaso-occlusive device
US20040098023A1 (en) * 2002-11-15 2004-05-20 Scimed Life Systems, Inc. Embolic device made of nanofibers
DE10325130B3 (en) 2003-06-04 2004-09-09 Czerwinski, Frank, Dr. Device for implanting occlusion helixes into hollow body chambers comprises a guiding and a detaching unit having a connecting part arranged on its distal end
US7645292B2 (en) * 2003-10-27 2010-01-12 Boston Scientific Scimed, Inc. Vaso-occlusive devices with in-situ stiffening elements
US20050267510A1 (en) * 2004-05-26 2005-12-01 Nasser Razack Device for the endovascular treatment of intracranial aneurysms

Patent Citations (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US23325A (en) * 1859-03-22 Filter
US46518A (en) * 1865-02-21 Henry wurtz
US6171326B2 (en) *
US3749085A (en) * 1970-06-26 1973-07-31 J Willson Vascular tissue removing device
US4020829A (en) * 1975-10-23 1977-05-03 Willson James K V Spring guide wire with torque control for catheterization of blood vessels and method of using same
US4509504A (en) * 1978-01-18 1985-04-09 Medline Ab Occlusion of body channels
US4493329A (en) * 1982-08-19 1985-01-15 Lynn Crawford Implantable electrode having different stiffening and curvature maintaining characteristics along its length
US5678296A (en) * 1987-09-30 1997-10-21 Lake Region Manufacturing, Inc. Hollow lumen cable apparatus
US5373619A (en) * 1987-09-30 1994-12-20 Lake Region Manufacturing Co., Inc. Method of making a hollow lumen cable
US5154705A (en) * 1987-09-30 1992-10-13 Lake Region Manufacturing Co., Inc. Hollow lumen cable apparatus
US5165421A (en) * 1987-09-30 1992-11-24 Lake Region Manufacturing Co., Inc. Hollow lumen cable apparatus
US4932419A (en) * 1988-03-21 1990-06-12 Boston Scientific Corporation Multi-filar, cross-wound coil for medical devices
US4951677A (en) * 1988-03-21 1990-08-28 Prutech Research And Development Partnership Ii Acoustic imaging catheter and the like
US5415634A (en) * 1990-08-23 1995-05-16 Devices For Vascular Intervention, Inc. Catheter having helical inflation lumen
US5536274A (en) * 1991-02-15 1996-07-16 pfm Produkterfur Die Medizin Spiral implant for organ pathways
US5217484A (en) * 1991-06-07 1993-06-08 Marks Michael P Retractable-wire catheter device and method
US5522822A (en) * 1992-10-26 1996-06-04 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5690666A (en) * 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5483022A (en) * 1994-04-12 1996-01-09 Ventritex, Inc. Implantable conductor coil formed from cabled composite wire
US5690671A (en) * 1994-12-13 1997-11-25 Micro Interventional Systems, Inc. Embolic elements and methods and apparatus for their delivery
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US5582619A (en) * 1995-06-30 1996-12-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
US6193728B1 (en) * 1995-06-30 2001-02-27 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US6013084A (en) * 1995-06-30 2000-01-11 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US6004338A (en) * 1995-06-30 1999-12-21 Target Therapeutics Inc. Stretch resistant vaso-occlusive coils
US5833705A (en) * 1995-06-30 1998-11-10 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils
US5853418A (en) * 1995-06-30 1998-12-29 Target Therapeutics, Inc. Stretch resistant vaso-occlusive coils (II)
US5766192A (en) * 1995-10-20 1998-06-16 Zacca; Nadim M. Atherectomy, angioplasty and stent method and apparatus
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5976162A (en) * 1996-04-10 1999-11-02 Target Therapeutics, Inc. Soft-ended fibered micro vaso-occlusive devices
US5833658A (en) * 1996-04-29 1998-11-10 Levy; Robert J. Catheters for the delivery of solutions and suspensions
US5823198A (en) * 1996-07-31 1998-10-20 Micro Therapeutics, Inc. Method and apparatus for intravasculer embolization
US5690667A (en) * 1996-09-26 1997-11-25 Target Therapeutics Vasoocclusion coil having a polymer tip
US6399886B1 (en) * 1997-05-02 2002-06-04 General Science & Technology Corp. Multifilament drawn radiopaque high elastic cables and methods of making the same
US6245090B1 (en) * 1997-11-07 2001-06-12 Salviac Limited Transcatheter occluding implant
US6159165A (en) * 1997-12-05 2000-12-12 Micrus Corporation Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand
US6168570B1 (en) * 1997-12-05 2001-01-02 Micrus Corporation Micro-strand cable with enhanced radiopacity
US6287318B1 (en) * 1998-02-13 2001-09-11 Target Therapeutics, Inc. Vaso-occlusive device with attached polymeric materials
US6063111A (en) * 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
US6015424A (en) * 1998-04-28 2000-01-18 Microvention, Inc. Apparatus and method for vascular embolization
US6299627B1 (en) * 1998-06-18 2001-10-09 Target Therapeutics, Inc. Water-soluble coating for bioactive vasoocclusive devices
US6299604B1 (en) * 1998-08-20 2001-10-09 Cook Incorporated Coated implantable medical device
US6136015A (en) * 1998-08-25 2000-10-24 Micrus Corporation Vasoocclusive coil
US6171326B1 (en) * 1998-08-27 2001-01-09 Micrus Corporation Three dimensional, low friction vasoocclusive coil, and method of manufacture
US6231590B1 (en) * 1998-11-10 2001-05-15 Scimed Life Systems, Inc. Bioactive coating for vaso-occlusive devices
US6179857B1 (en) * 1999-02-22 2001-01-30 Cordis Corporation Stretch resistant embolic coil with variable stiffness
US6645237B2 (en) * 1999-02-26 2003-11-11 Vascular Architects, Inc. Expandable coiled endoluminal prosthesis
US20020169473A1 (en) * 1999-06-02 2002-11-14 Concentric Medical, Inc. Devices and methods for treating vascular malformations
US6280457B1 (en) * 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
US6312421B1 (en) * 1999-07-23 2001-11-06 Neurovasx, Inc. Aneurysm embolization material and device
US6299619B1 (en) * 1999-10-04 2001-10-09 Microvention, Inc. Methods for embolizing a target vascular site
US6238403B1 (en) * 1999-10-04 2001-05-29 Microvention, Inc. Filamentous embolic device with expansible elements
US6296661B1 (en) * 2000-02-01 2001-10-02 Luis A. Davila Self-expanding stent-graft
US6699277B1 (en) * 2000-03-09 2004-03-02 Diseno Y Desarrollo Medica, S.A. De C.V. Stent with cover connectors
US6379382B1 (en) * 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US6723108B1 (en) * 2000-09-18 2004-04-20 Cordis Neurovascular, Inc Foam matrix embolization device
US20030208221A1 (en) * 2002-05-02 2003-11-06 Fozan El-Nounou Catheter with a coiled support member

Cited By (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8273100B2 (en) * 2002-07-31 2012-09-25 Microvention, Inc. Three element coaxial vaso-occlusive device
US8764788B2 (en) 2002-07-31 2014-07-01 Microvention, Inc. Multi-layer coaxial vaso-occlusive device
US8882796B2 (en) 2002-07-31 2014-11-11 Microvention, Inc. Three element coaxial vaso-occlusive device
US20040098028A1 (en) * 2002-07-31 2004-05-20 George Martinez Three element coaxial vaso-occlusive device
US20060173488A1 (en) * 2003-02-20 2006-08-03 Masahiro Takeuchi Indwelling instrument for forming embolus
US7803395B2 (en) 2003-05-15 2010-09-28 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
US20090062841A1 (en) * 2004-03-19 2009-03-05 Aga Medical Corporation Device for occluding vascular defects
US8777974B2 (en) 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US20080200945A1 (en) * 2004-03-19 2008-08-21 Aga Medical Corporation Device for occluding vascular defects
US9877710B2 (en) 2004-03-19 2018-01-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US20070265656A1 (en) * 2004-03-19 2007-11-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US8313505B2 (en) 2004-03-19 2012-11-20 Aga Medical Corporation Device for occluding vascular defects
US9039724B2 (en) * 2004-03-19 2015-05-26 Aga Medical Corporation Device for occluding vascular defects
US9445799B2 (en) 2004-03-19 2016-09-20 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects
US20060241690A1 (en) * 2004-03-19 2006-10-26 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US9445798B2 (en) 2004-03-19 2016-09-20 St. Jude Medical, Cardiology Division, Inc. Multi-layer braided structures for occluding vascular defects
US8398670B2 (en) 2004-03-19 2013-03-19 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body
US9050095B2 (en) 2004-09-22 2015-06-09 Covidien Lp Medical implant
US20060079926A1 (en) * 2004-10-07 2006-04-13 Rupesh Desai Vasoocclusive coil with biplex windings to improve mechanical properties
US8888806B2 (en) 2004-10-07 2014-11-18 DePuy Synthes Products, LLC Vasoocclusive coil with biplex windings to improve mechanical properties
US8535345B2 (en) * 2004-10-07 2013-09-17 DePuy Synthes Products, LLC Vasoocclusive coil with biplex windings to improve mechanical properties
US9307996B2 (en) 2005-12-13 2016-04-12 DePuy Synthes Products, Inc. Detachment actuator for use with medical device deployment systems
US7959676B2 (en) 2006-02-13 2011-06-14 Lanx, Inc. Method and apparatus for intervertebral disc support and repair
US20070213825A1 (en) * 2006-02-13 2007-09-13 Lanx, Llc Method and apparatus for intervertebral disc support and repair
US9259228B2 (en) 2006-06-15 2016-02-16 Microvention, Inc. Embolization device constructed from expansile polymer
US9724103B2 (en) 2006-06-15 2017-08-08 Microvention, Inc. Embolization device constructed from expansile polymer
US9451963B2 (en) 2006-06-15 2016-09-27 Microvention, Inc. Embolization device constructed from expansile polymer
US9877731B2 (en) 2006-06-15 2018-01-30 Microvention, Inc. Embolization device constructed from expansile polymer
US8062325B2 (en) 2006-07-31 2011-11-22 Codman & Shurtleff, Inc. Implantable medical device detachment system and methods of using the same
US20080097398A1 (en) * 2006-07-31 2008-04-24 Vladimir Mitelberg Interventional medical device component having an interrupted spiral section and method of making the same
US20080027561A1 (en) * 2006-07-31 2008-01-31 Vladimir Mitelberg Interventional medical device system having an elongation retarding portion and method of using the same
US7708704B2 (en) 2006-07-31 2010-05-04 Codman & Shurtleff, Pc Interventional medical device component having an interrupted spiral section and method of making the same
US8366720B2 (en) 2006-07-31 2013-02-05 Codman & Shurtleff, Inc. Interventional medical device system having an elongation retarding portion and method of using the same
US20080046093A1 (en) * 2006-08-18 2008-02-21 Richard Champion Davis Stretch resistant embolic coil
US8034073B2 (en) 2006-08-18 2011-10-11 Codman & Shurtleff, Inc. Stretch resistant embolic coil
US8801747B2 (en) 2007-03-13 2014-08-12 Covidien Lp Implant, a mandrel, and a method of forming an implant
US7766871B2 (en) 2007-03-27 2010-08-03 Intratech Medical Ltd. Spiral balloon catheter
US20100262124A1 (en) * 2007-03-27 2010-10-14 Intratech Medical Ltd. Spiral balloon catheter
US8079978B2 (en) 2007-03-27 2011-12-20 Intratech Medical Ltd. Spiral balloon catheter
US20080306440A1 (en) * 2007-03-27 2008-12-11 Eran Hirszowicz Spiral balloon catheter
US9486221B2 (en) 2007-12-21 2016-11-08 Microvision, Inc. Hydrogel filaments for biomedical uses
US8460332B2 (en) 2007-12-21 2013-06-11 Microvention, Inc. System and method of detecting implant detachment
US9242070B2 (en) 2007-12-21 2016-01-26 MicronVention, Inc. System and method for locating detachment zone of a detachable implant
US8192480B2 (en) 2007-12-21 2012-06-05 Microvention, Inc. System and method of detecting implant detachment
US20090210048A1 (en) * 2008-02-18 2009-08-20 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US8747453B2 (en) 2008-02-18 2014-06-10 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US20090318892A1 (en) * 2008-06-20 2009-12-24 Maria Aboytes Removable Core Implant Delivery Catheter
US9808252B2 (en) 2009-04-02 2017-11-07 Endoshape, Inc. Vascular occlusion devices
US20100268204A1 (en) * 2009-04-15 2010-10-21 Microvention, Inc. Implant Delivery System
US9968358B2 (en) 2009-04-15 2018-05-15 Microvention, Inc. Implant delivery system
US20100268201A1 (en) * 2009-04-15 2010-10-21 Microvention, Inc. Implant Delivery System
US9717500B2 (en) 2009-04-15 2017-08-01 Microvention, Inc. Implant delivery system
US9114200B2 (en) 2009-09-24 2015-08-25 Microvention, Inc. Injectable hydrogel filaments for biomedical uses
US9421121B2 (en) 2009-10-23 2016-08-23 Bayer Healthcare Llc Contraceptive devices and methods
US20110094519A1 (en) * 2009-10-23 2011-04-28 Vidya Gopal Contraceptive devices and methods
US8434489B2 (en) 2009-10-23 2013-05-07 Conceptus, Inc. Contraceptive devices and methods
US9993252B2 (en) 2009-10-26 2018-06-12 Microvention, Inc. Embolization device constructed from expansile polymer
US20110184455A1 (en) * 2009-10-26 2011-07-28 Microvention, Inc. Embolization Device Constructed From Expansile Polymer
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
WO2011094226A1 (en) * 2010-01-27 2011-08-04 Penumbra, Inc. Embolic implants
US20110184454A1 (en) * 2010-01-27 2011-07-28 Penumbra, Inc. Embolic implants
US9381109B2 (en) 2010-03-19 2016-07-05 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9561125B2 (en) 2010-04-14 2017-02-07 Microvention, Inc. Implant delivery device
US9510922B2 (en) 2010-05-21 2016-12-06 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US9707122B2 (en) 2010-07-26 2017-07-18 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US20160066924A1 (en) * 2010-10-12 2016-03-10 Boston Scientific Scimed, Inc. Vaso-occlusive device
US9186149B2 (en) * 2010-10-12 2015-11-17 Boston Scientific Scimed, Inc. Vaso-occlusive device
US20120089174A1 (en) * 2010-10-12 2012-04-12 Boston Scientific Scimed, Inc Vaso-occlusive device
US8360765B2 (en) 2011-01-07 2013-01-29 Covidien Lp Systems and method for forming a coaxial implant
US9456823B2 (en) 2011-04-18 2016-10-04 Terumo Corporation Embolic devices
US20120303053A1 (en) * 2011-05-23 2012-11-29 Stryker Nv Operations Limited Vaso-occlusive devices with in-situ stiffening
US9504474B2 (en) * 2011-05-23 2016-11-29 Stryker Corporation Vaso-occlusive devices with in-situ stiffening
WO2012161953A3 (en) * 2011-05-23 2013-03-28 Stryker Corporation Vaso-occlusive devices with in-situ stiffening
US20130131711A1 (en) * 2011-11-23 2013-05-23 Microvention, Inc. Embolic Device With Shaped Wire
WO2013109784A1 (en) * 2012-01-17 2013-07-25 Endoshape, Inc. Occlusion device for a vascular or biological lumen
CN104379070A (en) * 2012-01-17 2015-02-25 内形有限公司 Occlusion device for a vascular or biological lumen
US9011480B2 (en) 2012-01-20 2015-04-21 Covidien Lp Aneurysm treatment coils
US9687245B2 (en) 2012-03-23 2017-06-27 Covidien Lp Occlusive devices and methods of use
US9381278B2 (en) 2012-04-18 2016-07-05 Microvention, Inc. Embolic devices
US9439801B2 (en) * 2012-06-29 2016-09-13 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US20140000631A1 (en) * 2012-06-29 2014-01-02 Revent Medical, Inc. Systems and methods for treatment of sleep apnea
US20150250981A1 (en) * 2012-10-22 2015-09-10 Medtronic Ardian Luxembourg S.A.R.L. Catheters with enhanced flexibility and associated devices, systems, and methods
US9399115B2 (en) 2012-10-22 2016-07-26 Medtronic Ardian Luxembourg S.A.R.L. Catheters with enhanced flexibility and associated devices, systems, and methods
US9492635B2 (en) * 2012-10-22 2016-11-15 Medtronic Ardian Luxembourg S.A.R.L. Catheters with enhanced flexibility and associated devices, systems, and methods
US9060806B2 (en) * 2013-03-13 2015-06-23 Mallik Thatipelli Device and method for treating a chronic total occlusion
US20140277004A1 (en) * 2013-03-13 2014-09-18 Mallik Thatipelli Device and Method for Treating a Chronic Total Occlusion
US9681876B2 (en) 2013-07-31 2017-06-20 EMBA Medical Limited Methods and devices for endovascular embolization
US9848883B2 (en) 2013-07-31 2017-12-26 EMBA Medical Limited Methods and devices for endovascular embolization
US9713475B2 (en) 2014-04-18 2017-07-25 Covidien Lp Embolic medical devices
US20160206419A1 (en) * 2015-01-20 2016-07-21 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
US9999413B2 (en) * 2015-01-20 2018-06-19 Neurogami Medical, Inc. Micrograft for the treatment of intracranial aneurysms and method for use
WO2016154634A1 (en) * 2015-03-26 2016-09-29 Boston Scientific Scimed, Inc. Biologic-based expandable occlusion devices
US20160278785A1 (en) * 2015-03-26 2016-09-29 Boston Scientific Scimed, Inc. Biologic-based expandable occlusion devices
US10010328B2 (en) 2015-10-09 2018-07-03 NeuVT Limited Endovascular occlusion device with hemodynamically enhanced sealing and anchoring

Also Published As

Publication number Publication date Type
US20110245863A1 (en) 2011-10-06 application
EP1868511A1 (en) 2007-12-26 application
CA2601712A1 (en) 2006-09-28 application
CN101198280A (en) 2008-06-11 application
WO2006102329A1 (en) 2006-09-28 application
US8764788B2 (en) 2014-07-01 grant
JP2008534057A (en) 2008-08-28 application
CN101198280B (en) 2010-11-17 grant

Similar Documents

Publication Publication Date Title
US5830230A (en) Method of intracranial vascular embolotherapy using self anchoring coils
US6231586B1 (en) Three dimensional in-filling vaso-occlusive coils
US5766219A (en) Anatomically shaped vasoocclusive device and method for deploying same
US6024754A (en) Aneurysm closure method
US6585754B2 (en) Absorbable implantable vaso-occlusive member
US20030093111A1 (en) Device for vaso-occlusion and interventional therapy
US20040087998A1 (en) Device and method for treatment of a vascular defect
US20120283768A1 (en) Method and apparatus for the treatment of large and giant vascular defects
US20040153120A1 (en) Systems and methods of de-endothelialization
US20050095428A1 (en) Embolic compositions
US20040153025A1 (en) Systems and methods of de-endothelialization
US6306153B1 (en) Vasoocclusive coil
US20120259404A1 (en) Stent
US6616617B1 (en) Vasoocclusive device for treatment of aneurysms
US20030014075A1 (en) Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation
US5980550A (en) Water-soluble coating for bioactive vasoocclusive devices
US20030004568A1 (en) Coated combination vaso-occlusive device
US6605101B1 (en) Microcoil vaso-occlusive device with multi-axis secondary configuration
US20040006363A1 (en) Coaxial stretch-resistant vaso-occlusive device
US20040098023A1 (en) Embolic device made of nanofibers
US20090164013A1 (en) Hydrogel filaments for biomedical uses
US20030120302A1 (en) Vaso-occlusive device with serpentine shape
US7033374B2 (en) Microcoil vaso-occlusive device with multi-axis secondary configuration
US6500190B2 (en) Vascular embolization with an expansible implant
US20020087184A1 (en) Water-soluble coating for bioactive devices

Legal Events

Date Code Title Description
AS Assignment

Owner name: MICROVENTION, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MARTINEZ, GEORGE;REEL/FRAME:016025/0453

Effective date: 20050502